Health

When Blood Is a New Alternative Medicine for Pain Relief at Chula Pain Clinic

BANGKOK, April 11, 2023 /PRNewswire/ -- Chula Medicine researchers have successfully published an article on the injection of patient's own platelets rich plasma into the shoulderligaments resulting in pain reduction, heal torn ligaments and restore torn muscles as an alternative to surgery while...

2023-04-11 09:00 2564

SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices

* 'Zero WiredTM' and 'Zero EarbudsTM' named 'Winners' in the healthcare category for outstanding product design * SK Biopharmaceuticals' wearable devices earn a global accolade once again following the CES® Innovation Awards SEOUL, South Korea, April 10, 2023 /PRNewswire/ -- SK Biopharmaceuti...

2023-04-11 08:00 1829

Smith+Nephew signs exclusive distribution agreement to bring unique NAVBIT SPRINT™ solution for accurate acetabular cup alignment to Japan

Small, disposable, compact and simple to use navigation tool offers surgeons speed and reliability without the financial burden of capital equipment LONDON, April 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an agreement with NAV...

2023-04-11 07:00 3166

Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate

MELBOURNE, Australia, April 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a Phase I study of TLX101 investigational therapy (4-L-[131I]...

2023-04-11 05:00 2119

Asieris' subsidiary makes significant progress in its commercialization strategy by obtaining the "Drug Distribution License"

SHANGHAI, April 10, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that its subsidiary, Hainan Yahong ph...

2023-04-10 20:18 2086

DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES RESIDENCY AT JLABS @ SHANGHAI

SINGAPORE, April 10, 2023 /PRNewswire/ -- Respiree announced today that it has become a resident ofJohnson & Johnson Innovation – JLABS @ Shanghai ('JLABS') [1] from February 21, 2023 , in order to expand its footprint with the goal of deepening its relationships a...

2023-04-10 20:10 2807

JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus

SHANGHAI, April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the Na...

2023-04-10 19:30 3172

HistoIndex embarks on partnership with VCU's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health in the study of liver diseases

Advancing ML/AI-based technology in the study of liver diseases by furthering strategic partnerships using a stain-free digital pathology system. SINGAPORE, April 10, 2023 /PRNewswire/ -- Virginia Commonwealth University's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has annou...

2023-04-10 19:00 2498

Fit Hub Secures US$6.5M to Expand Tech-enabled Fitness Solutions in Indonesia

JAKARTA, Indonesia, April 10, 2023 /PRNewswire/ -- Indonesian fitness startup Fit Hub has successfully raised US$ 6.5 million to make health and wellness accessible to all Indonesians. The Company receivedUS$ 3 million in seed funding in early 2022 from Global Founders Capital, Trihill Capital, a...

2023-04-10 17:06 3046

GC Genome Announces Publication Demonstrating Feasibility of Liquid Biopsy Technology to Predict Radiation Therapy Response in Solid Tumors

YONGIN, South Korea, April 9, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a new study in Radiation Oncology Journal,which demonstrates the feasibility of cell-free DNA(cfDNA) monitoring to predict treatment response and detect min...

2023-04-10 11:39 1565

Asian Agri and Tanoto Foundation Sign Joint Agreement with Pelalawan District Government to Combat Stunting

PELALAWAN, Indonesia, April 10, 2023 /PRNewswire/ -- In support of the Indonesia government's efforts to combat stunting, Asian Agri and Tanoto Foundation signed a joint agreement with the Government of Pelalawan Regency,Riau Province. The agreement was signed by H. Nasarudin, Deputy Regent of ...

2023-04-10 10:21 2080

Chula Launches the Latest Parkinson's Gloves to Reduce Tremors

Doctors at King Chulalongkorn Memorial Hospital have developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication and risk from brain surgery. BANGKOK, April 10...

2023-04-10 09:30 3245

China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released

SHANGHAI, April 6, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the whole industry chain layout, announced its Nectin-4 targeted site-specific ADC asset (R&D code: 9MW2821) demonstrated promising clinical data. The preliminary data show positive therapeut...

2023-04-07 16:34 4339

Cooperation Agreement Concluded between BioKangtai and Biotis

-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugate Vaccine toIndonesia SHENZHEN, China, April 7, 2023 /PRNewswire/ -- On the morning of April 5, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as "BioMinhai"), a wholly-owned subsi...

2023-04-07 10:41 3727

Nuance Pharma Announces Dosing of First Patient in ENHANCE - China Phase III Trial for Chronic Obstructive Pulmonary Disease ("COPD")

SHANGHAI, April 6, 2023 /PRNewswire/ -- Nuance Pharma ("the Company") announces dosing of first patient in the ENHANCE - China Phase III Trial for the maintenance treatment of chronic obstructive pulmonary disease ("COPD") of its novel solution Ensifentrine in mainlandChina. Ensifentrine is a fi...

2023-04-07 10:00 2105

Compal Electronics Has Launched "AblatePal" RF Ablation System and "BreathePal" Bilevel Ventilator in Therapeutic Medical Device Market

TAIPEI, April 7, 2023 /PRNewswire/ -- Compal Electronics ("Compal"), a leading Taiwanese electronics company, has announced its expansion into the development of innovative therapeutic medical devices. Compal has launched a new radiofrequency ablation (RFA) system for percutaneous, intraoperative...

2023-04-07 09:00 3603

BGI Global Colorectal Cancer Survey Reveals Awareness Gaps and Affordability Concerns

HONG KONG, April 7, 2023 /PRNewswire/ -- To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics today released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world's third most commo...

2023-04-07 08:27 3935

AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering

NEW YORK, April 6, 2023 /PRNewswire/-- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platfo...

2023-04-07 07:15 4436

Wondercise to announce the new face of signature Live Motion Matching™ technology at FIBO 2023: a revolutionary fitness experience with wearables and live content

Groundbreaking motion tracking technology provides users with prime training content and real-time performance feedback * Wondercise will launch its newest release on the award-winning Live Motion Matching™ technology at FIBO 2023 with live demonstrations on site. * Patented fitness technolog...

2023-04-06 22:30 2988

IMG Launches New Plan for Expats & Globally Mobile Citizens, Global Prima Medical Insurance

INDIANAPOLIS, April 6, 2023 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, is excited to introduce a new international private medical insurance (IPMI) offering through their ALC Health brand. Global Prima Medical I...

2023-04-06 21:00 2376
1 ... 244245246247248249250 ... 848